Dynamics Special Purpose in an 8-K filing announced its shareholders voted in favor of the business combination with Senti Biosciences, a deal valued at $601 million.
The SPAC said 14,549,537 shares were redeemed, which is about 63% of the $230 million Dynamics held in trust.
Dynamics also raised PIPE funding of more than $66 million.
The deal is expected to close today, pending the satisfaction or waiver of closing conditions, after which Senti will trrade on the Nasdaq.
Senti is focused on circuit-engineered cell and gene therapies. Read more.
